AAAAAA

   
Results: 1-25 | 26-50 | 51-73
Results: 1-25/73
A randomized, open-label, comparative trial of zidovudine plus lamivudine versus zidovudine plus lamivudine plus didanosine in antiretroviral-naive HIV-1-infected Thai patients
Authors: Ungsedhapand, C Kroon, EDMB Suwanagool, S Ruxrungtham, K Yimsuan, N Sonjai, A Ubolyam, S Buranapraditkun, S Tiengrim, S Pakker, N Kunanusont, C Lange, JMA Cooper, DA Phanuphak, P
Citation: C. Ungsedhapand et al., A randomized, open-label, comparative trial of zidovudine plus lamivudine versus zidovudine plus lamivudine plus didanosine in antiretroviral-naive HIV-1-infected Thai patients, J ACQ IMM D, 27(2), 2001, pp. 116-123
Exhaust emissions from high speed passenger ferries
Authors: Cooper, DA
Citation: Da. Cooper, Exhaust emissions from high speed passenger ferries, ATMOS ENVIR, 35(24), 2001, pp. 4189-4200
HIV protease inhibitors protect apolipoprotein B from degradation by the proteasome: A potential mechanism for protease inhibitor-induced hyperlipidemia
Authors: Liang, JS Distler, O Cooper, DA Jamil, H Deckelbaum, RJ Ginsberg, HN Sturley, SL
Citation: Js. Liang et al., HIV protease inhibitors protect apolipoprotein B from degradation by the proteasome: A potential mechanism for protease inhibitor-induced hyperlipidemia, NAT MED, 7(12), 2001, pp. 1327-1331
Impact of HIV type 1 protease, reverse transcriptase, cleavage site, and p6 mutations on the virological response to quadruple therapy with saquinavir, ritonavir, and two nucleoside analogs
Authors: Kaufmann, GR Suzuki, K Cunningham, P Mukaide, M Kondo, M Imai, M Zaunders, J Cooper, DA
Citation: Gr. Kaufmann et al., Impact of HIV type 1 protease, reverse transcriptase, cleavage site, and p6 mutations on the virological response to quadruple therapy with saquinavir, ritonavir, and two nucleoside analogs, AIDS RES H, 17(6), 2001, pp. 487-497
Relative significance of different pathways of immune reconstitution in HIV type 1 infection as estimated by mathematical modeling
Authors: Kaufmann, GR Zaunders, J Murray, J Kelleher, AD Lewin, SR Solomon, A Smith, D Cooper, DA
Citation: Gr. Kaufmann et al., Relative significance of different pathways of immune reconstitution in HIV type 1 infection as estimated by mathematical modeling, AIDS RES H, 17(2), 2001, pp. 147-159
Novel deletion of HIV type 1 reverse transcriptase residue 69 conferring selective high-level resistance to nevirapine
Authors: Suzuki, K Kaufmann, GR Mukaide, M Cunningham, P Harris, C Leas, L Kondo, M Imai, M Pett, SL Finlayson, R Zaunders, J Kelleher, A Cooper, DA
Citation: K. Suzuki et al., Novel deletion of HIV type 1 reverse transcriptase residue 69 conferring selective high-level resistance to nevirapine, AIDS RES H, 17(13), 2001, pp. 1293-1296
High exposure to nevirapine in plasma is associated with an improved virological response in HIV-1-infected individuals
Authors: Veldkamp, AI Weverling, GJ Lange, JMA Montaner, JSG Reiss, P Cooper, DA Vella, S Hall, D Beijnen, JH Hoetelmans, RMW
Citation: Ai. Veldkamp et al., High exposure to nevirapine in plasma is associated with an improved virological response in HIV-1-infected individuals, AIDS, 15(9), 2001, pp. 1089-1095
Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy
Authors: Carr, A Miller, J Eisman, JA Cooper, DA
Citation: A. Carr et al., Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy, AIDS, 15(6), 2001, pp. 703-709
HIV protease inhibitor substitution in patients with lipodystrophy: a randomized, controlled, open-label, multicentre study
Authors: Carr, A Hudson, J Chuah, J Mallal, S Law, M Hoy, J Doong, N French, M Smith, D Cooper, DA
Citation: A. Carr et al., HIV protease inhibitor substitution in patients with lipodystrophy: a randomized, controlled, open-label, multicentre study, AIDS, 15(14), 2001, pp. 1811-1822
A commercially acceptable assessment technique for improved control of cabbage stem flea beetle feeding on winter oilseed rape
Authors: Walters, KFA Lane, A Cooper, DA Morgan, D
Citation: Kfa. Walters et al., A commercially acceptable assessment technique for improved control of cabbage stem flea beetle feeding on winter oilseed rape, CROP PROT, 20(10), 2001, pp. 907-912
An open-label randomized trial to evaluate different therapeutic strategies of combination therapy in HIV-1 infection: Design, rationale, and methodsof the initio trial
Authors: Babiker, AG Darbyshire, JH Cooper, DA Hooker, MH Withnall, R Yeni, P
Citation: Ag. Babiker et al., An open-label randomized trial to evaluate different therapeutic strategies of combination therapy in HIV-1 infection: Design, rationale, and methodsof the initio trial, CONTR CL TR, 22(2), 2001, pp. 160-175
Macular pigment optical density in a midwestern sample
Authors: Ciulla, TA Curran-Celantano, J Cooper, DA Hammond, BR Danis, RP Pratt, LM Riccardi, KA Filloon, TG
Citation: Ta. Ciulla et al., Macular pigment optical density in a midwestern sample, OPHTHALMOL, 108(4), 2001, pp. 730-737
Pharmacokinetics of stavudine and didanosine coadministered with nelfinavir in human immunodeficiency virus-exposed neonates
Authors: Rongkavilit, C Thaithumyanon, P Chuenyam, T Damle, BD Limpongsanurak, S Boonrod, C Srigritsanapol, A Hassink, EAM Hoetelmans, RMW Cooper, DA Lange, JMA Ruxrungtham, K Phanuphak, P
Citation: C. Rongkavilit et al., Pharmacokinetics of stavudine and didanosine coadministered with nelfinavir in human immunodeficiency virus-exposed neonates, ANTIM AG CH, 45(12), 2001, pp. 3585-3590
Serum concentrations of retinol, alpha-tocopherol and the carotenoids are influenced by diet, race and obesity in a sample of healthy adolescents
Authors: Neuhouser, ML Rock, CL Eldridge, AL Kristal, AR Patterson, RE Cooper, DA Neumark-Sztainer, D Cheskin, LJ Thornquist, MD
Citation: Ml. Neuhouser et al., Serum concentrations of retinol, alpha-tocopherol and the carotenoids are influenced by diet, race and obesity in a sample of healthy adolescents, J NUTR, 131(8), 2001, pp. 2184-2191
Increased turnover of CCR5(+) and redistribution of CCR5(-) CD4 T lymphocytes during primary human immunodeficiency virus type 1 infection
Authors: Zaunders, JJ Kaufmann, GR Cunningham, PH Smith, D Grey, P Suzuki, K Carr, A Goh, LE Cooper, DA
Citation: Jj. Zaunders et al., Increased turnover of CCR5(+) and redistribution of CCR5(-) CD4 T lymphocytes during primary human immunodeficiency virus type 1 infection, J INFEC DIS, 183(5), 2001, pp. 736-743
Relation between dietary intake, serum concentrations, and retinal concentrations of lutein and zeaxanthin in adults in a Midwest population
Authors: Curran-Celentano, J Hammond, BR Ciulla, TA Cooper, DA Pratt, LM Danis, RB
Citation: J. Curran-celentano et al., Relation between dietary intake, serum concentrations, and retinal concentrations of lutein and zeaxanthin in adults in a Midwest population, AM J CLIN N, 74(6), 2001, pp. 796-802
Synthesis and characterization of acidic high-silica faujasite-type gallosilicates
Authors: Maesen, TLM van Veen, JAR Cooper, DA van Vegchel, IM Gosselink, JW
Citation: Tlm. Maesen et al., Synthesis and characterization of acidic high-silica faujasite-type gallosilicates, J PHYS CH B, 104(4), 2000, pp. 716-720
Antiretroviral therapy of HIV-1 infection: established treatment strategies and new therapeutic options
Authors: Kaufmann, GR Cooper, DA
Citation: Gr. Kaufmann et Da. Cooper, Antiretroviral therapy of HIV-1 infection: established treatment strategies and new therapeutic options, CURR OPIN M, 3(5), 2000, pp. 508-514
Randomised, multicentre phase III study of saquinavir plus zidovudine pluszalcitabine in previously untreated or minimally pretreated HIV-infected patients
Authors: Stellbrink, HJ Hawkins, DA Clumeck, N Cooper, DA Myers, R Delfraissy, JF Gill, MJ Ramirez-Ronda, C Vella, S Salgo, M Bragman, K
Citation: Hj. Stellbrink et al., Randomised, multicentre phase III study of saquinavir plus zidovudine pluszalcitabine in previously untreated or minimally pretreated HIV-infected patients, CLIN DRUG I, 20(5), 2000, pp. 295-307
A randomised, open-label comparison of three highly active antiretroviral therapy regimens including two nucleoside analogues and indinavir for previously untreated HIV-1 infection: the OzCombo1 study
Authors: Carr, A Chuah, J Hudson, J French, M Hoy, J Law, M Sayer, D Emery, S Cooper, DA
Citation: A. Carr et al., A randomised, open-label comparison of three highly active antiretroviral therapy regimens including two nucleoside analogues and indinavir for previously untreated HIV-1 infection: the OzCombo1 study, AIDS, 14(9), 2000, pp. 1171-1180
Long-term immunological response in HIV-1-infected subjects receiving potent antiretroviral therapy
Authors: Kaufmann, GR Bloch, M Zaunders, JJ Smith, D Cooper, DA
Citation: Gr. Kaufmann et al., Long-term immunological response in HIV-1-infected subjects receiving potent antiretroviral therapy, AIDS, 14(8), 2000, pp. 959-969
Clinical features of acute HIV-1 infection: zidovudine-resistant isolates compared with zidovudine-sensitive isolates
Authors: Vanhems, P Gaudet, R Hirschel, B Imrie, A Conway, B Rouleau, D Vizzard, J Perrin, L Cooper, DA Yerly, S
Citation: P. Vanhems et al., Clinical features of acute HIV-1 infection: zidovudine-resistant isolates compared with zidovudine-sensitive isolates, AIDS, 14(8), 2000, pp. 1065-1067
AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients
Authors: Gartland, M Gerstoft, J Goebel, F Clumeck, N Cooper, DA Gatell, J Gazzard, B Gerstoft, J Goebel, F Lange, J Montaner, J Reiss, P Rozenbaum, W Vella, S Beveridge, A Cooper, DA Duncombe, C Gold, J Haberl, M Clumeck, N Luyts, D Montaner, J Rachlis, A Marina, R Gerstoft, J Wandall, JH Elbrond, B Molina, JM Pialloux, G Rozenbaum, W Beauvais, L Goebel, FD Staszewski, S Bruns, I Hug, M Reiss, P Lange, J Frissen, PHJ van der Ende, ME Bosboom, M Baas, C Milazzo, F Moroni, M Panebianco, R Clotet, B Artigas, JMG Gonzalez-Lahoz, J Leal, M Rodriguez-Lopo, C Gandarias, B Gazzard, B Johnson, M McKinley, S Page, V Watkins, K Sandstrom, E Belsey, E Darbyshire, J Chodakewitz, J Isaacs, R Jonas, L Meibohm, A Coughlan, M Fiddian, P Gartland, M Harrigan, R Larder, B Maguire, M Millard, J Moore, S Patel, K Shortino, D Tisdale, M Vafidis, I Yeo, J
Citation: M. Gartland et al., AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients, AIDS, 14(4), 2000, pp. 367-374
Comparison of clinical features, CD4 and CD8 responses among patients withacute HIV-1 infection from Geneva, Seattle and Sydney
Authors: Vanhems, P Hughes, J Collier, AC Vizzard, J Perrin, L Cooper, DA Hirschel, B Corey, L
Citation: P. Vanhems et al., Comparison of clinical features, CD4 and CD8 responses among patients withacute HIV-1 infection from Geneva, Seattle and Sydney, AIDS, 14(4), 2000, pp. 375-381
A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome
Authors: Carr, A Miller, J Law, M Cooper, DA
Citation: A. Carr et al., A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome, AIDS, 14(3), 2000, pp. F25-F32
Risultati: 1-25 | 26-50 | 51-73